Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

LONDON MARKET MIDDAY: Record-setting FTSE 100 shines on tariff hope

10th Jul 2025 12:11

(Alliance News) - Stock prices in Europe were on the up heading into Thursday afternoon, with risk sentiment positive on tariff optimism and after strong trade in New York overnight. Read More

LONDON BROKER RATINGS: Jefferies says buy BAT and Imperial Brands

9th Jul 2025 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON MARKET OPEN: Europe rises despite new US tariff mayhem

9th Jul 2025 08:56

(Alliance News) - Stock prices in Europe opened in the green on Wednesday, shaking off a more stern tone from US President Donald Trump on trade policy, though the threat of sector tariffs on copper and pharmaceuticals hit miners and drug makers. Read More

CORRECT: AstraZeneca bladder cancer treatment secures EU approval

4th Jul 2025 17:19

(Correcting name of trial, primary endpoint and Dave Fredrickson's title.) Read More

LONDON MARKET CLOSE: Stocks fade as tariff deadline looms large

4th Jul 2025 16:58

(Alliance News) - London's FTSE 100 ended flat as tariff worries kept enthusiasm to a minimum on Friday, while the pound edged slightly lower after a dramatic week in Westminster. Read More

LONDON MARKET MIDDAY: Europe down ahead of US tariff decision deadline

4th Jul 2025 11:58

(Alliance News) - London's blue chip index remained lower at midday on Friday, as investors weigh China's decision to slap levies on major European brandy exporters, and as US trading partners brace for letters on their respective tariff rates. Read More

AstraZeneca bladder cancer treatment Imfinzi secures EU approval

4th Jul 2025 08:02

(Alliance News) - AstraZeneca PLC on Friday said Imfinzi is "poised to transform the standard of care" as it reported the bladder cancer treatment cleared a European regulatory milestone. Read More

LONDON BRIEFING: AstraZeneca wins EU nod for bladder cancer therapy

4th Jul 2025 07:58

(Alliance News) - London's FTSE 100 is called lower on Friday, as investors await a potential US announcement on tariff rates for trading partners and the UK prime minister reflects on his "good relationship" with US President Donald Trump. Read More

LONDON MARKET CLOSE: Pound climbs, bond yields ease as PM backs Reeves

3rd Jul 2025 16:58

(Alliance News) - The FTSE 100 and sterling rallied, while the bond market calmed on Thursday as Keir Starmer supported his chancellor, reassuring markets that a change at the Treasury wasn't on the cards. Read More

LONDON BROKER RATINGS: Berenberg cuts Rio Tinto; UBS cuts Fresnillo

3rd Jul 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

PRESS: AstraZeneca CEO Soriot wants to move listing to the US - Times

1st Jul 2025 17:43

(Alliance News) - The long-serving chief executive of AstraZeneca, Britain's most valuable public company, would like to move the stock market listing to the US, the Times reported on Tuesday. Read More

LONDON MARKET CLOSE: FTSE 100 advances, outperforming European peers

1st Jul 2025 17:02

(Alliance News) - London's FTSE 100 ended an up and down trading session firmly in the green on Tuesday despite ongoing US trade policy uncertainty and mixed economic data. Read More

LONDON BRIEFING: Bunzl trades in line; Telecom Plus profit climbs

24th Jun 2025 07:52

(Alliance News) - London's FTSE 100 is called to open higher, while the dollar and Brent fell as US President Donald Trump announced a ceasefire in the Iran-Israel conflict. Read More

AstraZeneca and Daiichi hail US approval of Datroway for lung cancer

24th Jun 2025 03:54

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said Datroway has secured US Food & Drug Administration approval for use in adult patients with previously treated advanced EGFR-mutated non-small cell lung cancer. Read More

LONDON MARKET CLOSE: FTSE 100 underperforms Europe despite Iran talks

20th Jun 2025 17:04

(Alliance News) - London's FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and drug stocks offset hopes for progress in the Israel-Iran conflict. Read More

LONDON MARKET CLOSE: Stocks up on hopes of thaw to Middle East tension

16th Jun 2025 17:05

(Alliance News) - The FTSE 100 ended higher on Monday, just shy of a record closing high, on reports Iran is willing to resume nuclear talks with the US. Read More

AstraZeneca boosts China ties with up to USD5.3 billion partnership

13th Jun 2025 10:19

(Alliance News) - AstraZeneca PLC on Friday reported an AI-focused collaboration with Shijiazhuang City, China-based CSPC Pharmaceutical Group Ltd, boosting its existing presence in the country. Read More

AstraZeneca says Enhertu slashes disease progression risk in cancer

2nd Jun 2025 14:23

(Alliance News) - AstraZeneca PLC on Monday said Enhertu reduced the risk of disease progression in a form of breast cancer. Read More

Hutchmed reports progress in late-stage lung cancer trial

2nd Jun 2025 11:19

(Alliance News) - Hutchmed China Ltd on Monday said its combination therapy for a specific form of advanced lung cancer significantly delayed disease progression compared to chemotherapy, based on phase III trial data presented at a major oncology conference. Read More

LONDON BRIEFING: Stocks edge down as renewed trade tensions continue

2nd Jun 2025 07:48

(Alliance News) - The FTSE 100 was called slightly lower on Monday, ahead of manufacturing PMI data from the UK and other regions, and following US President Donald Trump's claim that the US will double steel and aluminium import tariffs. Read More

FTSE 100 Latest

Value8,975.66

Change108.64